Immix Biopharma, Inc. beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q1 FY2026 | $-0.21 | — | — | Miss |
| Q1 FY2026 | $-0.14 | — | — | Miss |
| Q12026 FY2026 | $-0.21 | $-0.18 | +14.3% | Beat |
Back to IMMX overview · IMMX holders · IMMX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.